Your browser doesn't support javascript.
loading
Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGS.
Callens, Celine; Bidard, Francois-Clement; Curto-Taribo, Anaïs; Trabelsi-Grati, Olfa; Melaabi, Samia; Delaloge, Suzette; Hardy-Bessard, Anne-Claire; Bachelot, Thomas; Clatot, Florian; De La Motte Rouge, Thibault; Canon, Jean-Luc; Arnould, Laurent; Andre, Fabrice; Marques, Sandrine; Stern, Marc-Henri; Pierga, Jean-Yves; Vincent-Salomon, Anne; Benoist, Camille; Jeannot, Emmanuelle; Berger, Frederique; Bieche, Ivan; Pradines, Anne.
Afiliação
  • Callens C; Pharmacogenomic Unit, Genetics Laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie and PSL University, 75005 Paris, France.
  • Bidard FC; Department of Medical Oncology, Institut Curie, UVSQ/Paris Saclay University, 92210 Saint Cloud, France.
  • Curto-Taribo A; Circulating Tumor Biomarkers Laboratory, Inserm CIC-BT 1428, Institut Curie, 75005 Paris, France.
  • Trabelsi-Grati O; Pharmacogenomic Unit, Genetics Laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie and PSL University, 75005 Paris, France.
  • Melaabi S; Pharmacogenomic Unit, Genetics Laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie and PSL University, 75005 Paris, France.
  • Delaloge S; Pharmacogenomic Unit, Genetics Laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie and PSL University, 75005 Paris, France.
  • Hardy-Bessard AC; Department of Medical Oncology, Gustave Roussy, 94800 Villejuif, France.
  • Bachelot T; Department of Medical Oncology, Centre Armoricain d'Oncologie, 22190 Plérin, France.
  • Clatot F; Department of Medical Oncology, Centre Léon Bérard, 69000 Lyon, France.
  • De La Motte Rouge T; Department of Medical Oncology, Centre Henri Becquerel, 76000 Rouen, France.
  • Canon JL; Department of Medical Oncology, Centre Eugène Marquis, 35000 Rennes, France.
  • Arnould L; Department of Medical Oncology, Grand Hôpital de Charleroi, 6000 Charleroi, Belgique.
  • Andre F; Department of Pathology, Centre Georges François Leclerc, 21000 Dijon, France.
  • Marques S; Department of Medical Oncology, Gustave Roussy, 94800 Villejuif, France.
  • Stern MH; Research and Development Department, UNICANCER, 75013 Paris, France.
  • Pierga JY; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) Team, Institut Curie, PSL Research University, 75005 Paris, France.
  • Vincent-Salomon A; Circulating Tumor Biomarkers Laboratory, Inserm CIC-BT 1428, Institut Curie, 75005 Paris, France.
  • Benoist C; Department of Medical Oncology, Institut Curie & Université de Paris, 75005 Paris, France.
  • Jeannot E; Department of Diagnostic and Theranostic Medicine, Institut Curie, 75005 Paris, France.
  • Berger F; Bio-informatic Clinical Unit, Department of Diagnostic and Theranostic Medicine, Institut Curie and PSL University, 75005 Paris, France.
  • Bieche I; Pharmacogenomic Unit, Genetics Laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie and PSL University, 75005 Paris, France.
  • Pradines A; Biometry Unit, Institut Curie and PSL Research University, 75005 Paris and 92210 Saint-Cloud, France.
Anal Chem ; 94(16): 6297-6303, 2022 04 26.
Article em En | MEDLINE | ID: mdl-35416669
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sequenciamento de Nucleotídeos em Larga Escala / DNA Tumoral Circulante Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Anal Chem Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sequenciamento de Nucleotídeos em Larga Escala / DNA Tumoral Circulante Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Anal Chem Ano de publicação: 2022 Tipo de documento: Article